Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 50 years of age or older
- People who have been diagnosed with mild to moderate Alzheimer's dementia
- People who completed at least an eighth grade level of education
- Women who have gone through menopause
- People whose score on a standard memory and thinking test (called the MMSE) falls between 16 and 26
- People who are able to give their own consent to join the study, or who have a spouse, family member, or other representative able to give consent on their behalf
- People who are willing and able to follow the study's requirements
- People who are taking a cholinesterase inhibitor and/or memantine, provided that medication was prescribed at least 3 months before the screening visit and the dose has been stable for at least 60 days before screening, and can remain at that dose for the whole study
- People who have a spouse, family member, or professional caregiver who agrees to and is capable of supporting the person's participation — including answering questions about their condition, managing their medication, and applying and supervising the daily treatment sessions
- People who a clinician has assessed as physically suitable to take part in the study
Who may not be able to join:
- People who cannot give their own consent and do not have a surrogate available to consent on their behalf
- People with a history of epilepsy or epileptic seizures
- People currently taking medication that lowers the threshold for seizures
- People who have a current or past diagnosis of depression, bipolar disorder, a psychotic disorder, or any other neurological or psychiatric condition that the study investigator considers would interfere with the study
- People experiencing severe agitation that would interfere with study procedures
- People who have had an alcohol or substance use disorder (as defined by DSM-5) within the last 5 years, or who are experiencing severe sleep deprivation
- People who have had major surgery — defined as major abdominal, vascular, or chest surgery requiring general anaesthesia and resulting in more than one week in hospital — within the past 4 weeks
- People whose head shape or size prevents the treatment device from fitting properly
- People who have taken part in another clinical trial within the past 30 days
- People who have metal implants in the head, such as cochlear implants, implanted brain stimulators, neurostimulators, or aneurysm clips (note: metal implants in the mouth are generally not excluded — confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 551-996-1140
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog); Mini-Mental Status Exam (MMSE); Global Deterioration questionnaire; Quality of Life Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.